Acquisitions and agreements keep Verfora ahead

24 January 2022 - Deborah Wilkes


Acquisitions and new in-licensing agreements helped lift sales at Galenica’s Products & Brands business – which mainly consists of the Verfora consumer healthcare unit – by 17.8% to CHF132 million (USD142 million) in 2021.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: